Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04488354 · ClinicalTrials.gov registry record · Phase 1
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
A Phase 1 study, sponsored by Calibr, a division of Scripps Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT04488354 is a Phase 1 study that has completed, run by Calibr, a division of Scripps Research. The registered enrollment target is 16 participants.
The verdict
NCT04488354, a Phase 1 study, has completed, sponsored by Calibr, a division of Scripps Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study is designed as a long-term follow-up study of participants who have receive genetically modified autologous CLBR001 CAR-T cells
Interventions
- COMBINATION_PRODUCT CLBR001 and SWI019
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2025-10-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04488354
The ClinicalTrials.gov registry entry for NCT04488354 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Calibr, a division of Scripps Research, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CLBR001 and SWI019 is the first listed.
NCT04488354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04488354 about?
NCT04488354 is a clinical study titled "Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T". This study is designed as a long-term follow-up study of participants who have receive genetically modified autologous CLBR001 CAR-T cells
What is the current status of trial NCT04488354?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2021-01-21. Estimated completion is 2025-10-06.
What interventions are being tested in trial NCT04488354?
The interventions under investigation include: CLBR001 and SWI019 (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04488354?
This trial is sponsored by Calibr, a division of Scripps Research, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.